Rapid-response manufacturing of adenovirus-vectored vaccines - Nature Biotechnology

Norge Nyheter Nyheter

Rapid-response manufacturing of adenovirus-vectored vaccines - Nature Biotechnology
Norge Siste Nytt,Norge Overskrifter
  • 📰 NatureBiotech
  • ⏱ Reading Time:
  • 42 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 63%

Rapid-response manufacturing of adenovirus-vectored vaccines

). This more than doubles facility output as compared to a facility lacking perfusion in the seed train and using a single production bioreactor, while requiring a proportionately small increase in footprint. Using perfusion for more cell expansion at– 1 reduces the cycle time of the production bioreactors. A single purification train remains sufficient to process the output from both production reactors.

Under an alternative assumption of short-term maximum-capacity operation for emergency response, we estimate that eight such facilities could provide a total of 1 billion doses per month. Although substantial, this would be smaller than the network of facilities that produced ChAdOx1 nCoV-19 in 2021. We believe several existing facilities would be suitable.

Quality control testing is rate limiting for vaccine availability. The timeline we have suggested allows 16 days for release testing of the first clinical trial batch and 35 days for testing the first commercial batch. The difference is due to performing 28-day in vitro culture-based assays for adventitious viral agents and replication-competent adenovirus for commercial material, whereas nucleic acid-based assays are used for clinical trial material.

Vi har oppsummert denne nyheten slik at du kan lese den raskt. Er du interessert i nyhetene kan du lese hele teksten her. Les mer:

NatureBiotech /  🏆 231. in US

Norge Siste Nytt, Norge Overskrifter

Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.

Women build strength in numbers - Nature BiotechnologyWomen build strength in numbers - Nature BiotechnologyWomen build strength in numbers Women’s networks are strong, and making a difference IWD2023 EmbraceEquity WomenInBiotech
Les mer »

Tuning plant phenotypes by precise, graded downregulation of gene expression - Nature BiotechnologyTuning plant phenotypes by precise, graded downregulation of gene expression - Nature BiotechnologyTuning plant phenotypes by precise, graded downregulation of gene expression
Les mer »

Houston Botanic Garden's Intertwined Balances Art, NatureHouston Botanic Garden's Intertwined Balances Art, NatureSteve Tobin's Intertwined is on displace at Houston Botanic Gardens. The pieces spiral, dance and provoke thought through Aug. 13 as they dramatically capture the unseen power of the natural world while celebrating the important systems that give life to the Garden’s tropical, sub-tropical, and arid collections.
Les mer »

Facilitating limb movement after stroke - Nature MedicineFacilitating limb movement after stroke - Nature MedicineA new study reveals epidural spinal cord stimulation as a potential new tool for stroke recovery. Read the News and Views from David Reinkensmeyer and colleagues. UCIrvine jointbme
Les mer »

Gender, education expansion and intergenerational educational mobility around the world - Nature Human BehaviourGender, education expansion and intergenerational educational mobility around the world - Nature Human BehaviourAgainst the backdrop of the world expansion of education and changes in parents’ educational pairing patterns, Hu and Qian provide global evidence on the importance of gender and the mother in intergenerational educational mobility.
Les mer »

Anomalous intense coherent secondary photoemission from a perovskite oxide - NatureNature research paper: Anomalous intense coherent secondary photoemission from a perovskite oxide
Les mer »



Render Time: 2025-03-11 21:41:02